Eli Lilly

LLY · NYSE · Pharma · United States

$1,098.57

-2.1%

as of Jun 18, 2026, 8:05 PM

52-week range

$623.78 – $1,182.73

P/E (TTM)

46.1

Revenue (FY2025)

$65.2B

Net margin

31.7%

ROE

77.8%

Volume

4,441,204

New to these? P/E, ROE, ROCE and more in Learn.

Ask MarketChacha about LLY

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Revenue trend

Yearly

PeriodRevenueNet profitEPSNet marginROE
FY2025$65.2B$20.6B22.9531.7%77.8%
FY2024$45.0B$10.6B11.7123.5%74.2%
FY2023$34.1B$5.2B5.8015.4%48.6%

Quarterly

PeriodRevenueNet profitEPSNet marginROE
2026Q1$19.8B$7.4B8.2637.4%
2025Q3$17.6B$5.6B6.2131.7%
2025Q2$15.6B$5.7B6.2936.4%
2025Q1$12.7B$2.8B3.0621.7%
2024Q3$11.4B$970.3M1.078.5%
2024Q2$11.3B$3.0B3.2826.3%
2024Q1$8.8B$2.2B2.4825.6%
2023Q3$9.5B$-57.4M-0.06-0.6%
2023Q2$8.3B$1.8B1.9521.2%
2023Q1$7.0B$1.3B1.4919.3%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

In the news

Education and discussion only — not investment advice. Data from official filings (SEC/BSE), Yahoo Finance, and Google News. Verify with the linked sources before acting.